About Index Trending news
Analyze
Top 50 Pricing
Intellia Therapeutics

Intellia Therapeutics

Work at Intellia Therapeutics? Add yourself to this profile

Intellia Therapeutics

Treating genetic disease at the cutting edge: Intellia Therapeutics is a CRISPR/Cas9 focused biotechnology company.

Elsewhere

Alexa global traffic share

Twitter followers

05 May 2016
$108,000,000
IPO
01 Sep 2015
$70,000,000
Venture capital (Series B)
18 Nov 2014
$15,000,000
Venture capital (Series A)